Whitehawk Therapeutics (WHWK) Total Liabilities (2018 - 2025)
Historic Total Liabilities for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $9.8 million.
- Whitehawk Therapeutics' Total Liabilities fell 4147.95% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 4147.95%. This contributed to the annual value of $17.8 million for FY2024, which is 3447.55% down from last year.
- Latest data reveals that Whitehawk Therapeutics reported Total Liabilities of $9.8 million as of Q3 2025, which was down 4147.95% from $8.8 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Total Liabilities registered a high of $27.2 million during Q4 2023, and its lowest value of $2.1 million during Q1 2021.
- Over the past 5 years, Whitehawk Therapeutics' median Total Liabilities value was $19.8 million (recorded in 2023), while the average stood at $17.6 million.
- Its Total Liabilities has fluctuated over the past 5 years, first surged by 80150.11% in 2022, then plummeted by 6164.53% in 2025.
- Whitehawk Therapeutics' Total Liabilities (Quarter) stood at $21.5 million in 2021, then increased by 20.25% to $25.9 million in 2022, then grew by 5.29% to $27.2 million in 2023, then crashed by 34.48% to $17.8 million in 2024, then crashed by 44.8% to $9.8 million in 2025.
- Its Total Liabilities was $9.8 million in Q3 2025, compared to $8.8 million in Q2 2025 and $12.3 million in Q1 2025.